Article

Bone loss in RA may predict radiographic damage

Generalized bone mineral density (BMD) may be used as a predictor of subsequent radiographic damage in African Americans who have recent-onset rheumatoid arthritis (RA).

Generalized bone mineral density (BMD) may be used as a predictor of subsequent radiographic damage in African Americans who have recent-onset rheumatoid arthritis (RA). Radiographic damage and reduced generalized BMD in patients who have RA may share a common mechanism.

Zhang and associates examined changes in BMD in 141 patients from the multicenter Consortium for the Longitudinal Evaluation of African Americans with Early RA registry. They measured BMD at the femoral neck or spine and calculated each patient’s T score at baseline. They also obtained hand and wrist films (evaluated using the modified Sharp/van der Heijde score [SHS]).

More patients had osteopenia or osteoporosis in the femoral neck than in the spine (44.9% vs 38.6% of patients). However, persons with generalized bone loss had a higher average SHS and more radiographic progression of RA than those who had normal BMD. After controlling for multiple variables, low BMD in the femoral neck was a more significant predictor of RA progression and was more closely correlated with SHS at 3 years than low BMD in the spine.

The authors noted that their results raise the question of whether bone density is already reduced in patients with early RA compared with the general population.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.